Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)
Clinical trial NCT01418352 · COMPLETED
Trial details
- NCT number
- NCT01418352
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-02
- Primary completion
- 2014-03-12
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.